# FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

> **NCT00293670** · PHASE4 · UNKNOWN · sponsor: **Tampere University** · enrollment: 573 (—)

## Conditions studied

- Patients With T1-4 Advanced Prostate Cancer

## Interventions

- **DRUG:** Goserelin (Zoladex)

## Key facts

- **NCT ID:** NCT00293670
- **Lead sponsor:** Tampere University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1997-05
- **Primary completion:** —
- **Final completion:** 2015-04
- **Target enrollment:** 573 (—)
- **Last updated:** 2006-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293670, "FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00293670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*